Found: 40
Select item for more details and to access through your institution.
Validating the Baveno Elastography Criteria of Advanced Liver Fibrosis in Two-Dimensional Shear Wave Elastography: A Prospective Pathology-Based Study.
- Published in:
- Digestive Diseases, 2024, v. 42, n. 5, p. 452, doi. 10.1159/000539167
- By:
- Publication type:
- Article
Characteristics of Symptom Presentation and Risk Factors in Patients with Erosive Esophagitis and Nonerosive Reflux Disease.
- Published in:
- Medical Principles & Practice, 2014, v. 23, n. 5, p. 460, doi. 10.1159/000363661
- By:
- Publication type:
- Article
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac348
- By:
- Publication type:
- Article
The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma.
- Published in:
- Journal of Digestive Diseases, 2020, v. 21, n. 5, p. 287, doi. 10.1111/1751-2980.12866
- By:
- Publication type:
- Article
Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.
- Published in:
- Liver International, 2003, v. 23, n. 6, p. 426, doi. 10.1111/j.1478-3231.2003.00875.x
- By:
- Publication type:
- Article
Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 5, p. 1, doi. 10.1002/jmv.29675
- By:
- Publication type:
- Article
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 4, p. 434, doi. 10.1111/apt.16697
- By:
- Publication type:
- Article
The prevalence and risk factors of hepatitis B flares in chronic hepatitis B patients receiving glucocorticoid pulse therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 5, p. 616, doi. 10.1159/000520721
- By:
- Publication type:
- Article
Disseminated Cryptococcus over pancreas, lung, and brain: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Assessment of Educational Needs and Quality of Life of Chronic Hepatitis Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2612, doi. 10.3390/jcm13092612
- By:
- Publication type:
- Article
Direct-Acting Antiviral Drugs Reduce Fibromyalgia Symptoms in Patients with Chronic Hepatitis C.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/jcm11185327
- By:
- Publication type:
- Article
The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4874, doi. 10.3390/jcm11164874
- By:
- Publication type:
- Article
Critically-Ill Patients with Biliary Obstruction and Cholangitis: Bedside Fluoroscopic-Free Endoscopic Drainage versus Percutaneous Drainage.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1869, doi. 10.3390/jcm11071869
- By:
- Publication type:
- Article
Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1444, doi. 10.3390/jcm11051444
- By:
- Publication type:
- Article
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4883, doi. 10.3390/jcm10214883
- By:
- Publication type:
- Article
Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3296, doi. 10.3390/jcm10153296
- By:
- Publication type:
- Article
Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 6, p. 1145, doi. 10.1111/1756-185X.13582
- By:
- Publication type:
- Article
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
- Published in:
- Liver International, 2016, v. 36, n. 12, p. 1755, doi. 10.1111/liv.13253
- By:
- Publication type:
- Article
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66182-8
- By:
- Publication type:
- Article
Establishing the blood reference interval of pancreatic elastase‐1: A prospective study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 1, p. 117, doi. 10.1111/jgh.15685
- By:
- Publication type:
- Article
Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221958
- By:
- Publication type:
- Article
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 8, p. 1946, doi. 10.1002/ijc.22045
- By:
- Publication type:
- Article
Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2316, doi. 10.3390/v14112316
- By:
- Publication type:
- Article
Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169655
- By:
- Publication type:
- Article
Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.
- Published in:
- Scientific Reports, 2015, p. 11710, doi. 10.1038/srep11710
- By:
- Publication type:
- Article
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 7, p. 609, doi. 10.1007/s00535-024-02101-2
- By:
- Publication type:
- Article
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32060-7
- By:
- Publication type:
- Article
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 11, p. 1579, doi. 10.1111/jvh.13603
- By:
- Publication type:
- Article
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 6, p. 568, doi. 10.1111/jvh.13265
- By:
- Publication type:
- Article
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Specific adverse events predict survival rates in a Chinese population diagnosed with hepatocellular carcinoma and treated with sorafenib.
- Published in:
- JGH Open, 2019, v. 3, n. 1, p. 10, doi. 10.1002/jgh3.12096
- By:
- Publication type:
- Article
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 11, p. 1977, doi. 10.1111/jgh.14672
- By:
- Publication type:
- Article
Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
- Published in:
- Journal of Gastroenterology & Hepatology, 2006, v. 21, n. 12, p. 1789, doi. 10.1111/j.1440-1746.2006.04677.x
- By:
- Publication type:
- Article
Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.
- Published in:
- Journal of Gastroenterology & Hepatology, 2003, v. 18, n. 2, p. 162, doi. 10.1046/j.1440-1746.2003.02938.x
- By:
- Publication type:
- Article
Mediation of transcatheter arterial chemoembolization induced gastric slow-wave dysrhythmia by endogenous prostaglandin<sup>1</sup>.
- Published in:
- Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 1, p. 46, doi. 10.1046/j.1440-1746.2002.02659.x
- By:
- Publication type:
- Article
On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174046
- By:
- Publication type:
- Article